Advertisement
LUNG vs XVIPF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUNG is a Buy and XVIPF is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LUNG’s FA Score shows that 1 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).
- LUNG’s FA Score: 1 green, 4 red.
- XVIPF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LUNG’s TA Score shows that 5 TA indicator(s) are bullish while XVIPF’s TA Score has 3 bullish TA indicator(s).
- LUNG’s TA Score: 5 bullish, 3 bearish.
- XVIPF’s TA Score: 3 bullish, 3 bearish.
Price Growth
LUNG (@Medical/Nursing Services) experienced а +2.96% price change this week, while XVIPF (@Medical/Nursing Services) price change was +0.28% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.
Reported Earning Dates
LUNG is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Medical/Nursing Services (-1.97% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| LUNG | XVIPF | LUNG / XVIPF | |
| Capitalization | 70.9M | 579M | 12% |
| EBITDA | -51.84M | 182M | -28% |
| Gain YTD | -74.374 | -53.644 | 139% |
| P/E Ratio | N/A | 51.05 | - |
| Revenue | 90.5M | 823M | 11% |
| Total Cash | 84.2M | 323M | 26% |
| Total Debt | 56.8M | 111M | 51% |
XVIPF | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 84 | |
PRICE GROWTH RATING 1..100 | 92 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| LUNG | XVIPF | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 71% | 3 days ago 41% |
| Stochastic ODDS (%) | 3 days ago 82% | 3 days ago 54% |
| Momentum ODDS (%) | 3 days ago 77% | 3 days ago 38% |
| MACD ODDS (%) | 6 days ago 81% | 3 days ago 42% |
| TrendWeek ODDS (%) | 3 days ago 78% | 3 days ago 43% |
| TrendMonth ODDS (%) | 3 days ago 83% | 3 days ago 51% |
| Advances ODDS (%) | 7 days ago 77% | N/A |
| Declines ODDS (%) | 4 days ago 83% | 20 days ago 58% |
| BollingerBands ODDS (%) | 3 days ago 90% | N/A |
| Aroon ODDS (%) | 3 days ago 74% | 3 days ago 63% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FTDZX | 151.86 | 2.65 | +1.78% |
| Franklin Biotechnology Discovery Adv | |||
| HBLCX | 14.67 | 0.05 | +0.36% |
| Hartford Balanced Income C | |||
| JLGAX | 21.71 | 0.07 | +0.32% |
| JAG Large Cap Growth A | |||
| TLGCX | 9.70 | 0.03 | +0.31% |
| Timothy Plan Large/Mid Cap Growth C | |||
| BCSFX | 26.98 | 0.02 | +0.07% |
| Brown Capital Mgmt Intl Sm Co Instl | |||
LUNG and
Correlation & Price change
A.I.dvisor indicates that over the last year, LUNG has been loosely correlated with BDX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LUNG jumps, then BDX could also see price increases.
| Ticker / NAME | Correlation To LUNG | 1D Price Change % | ||
|---|---|---|---|---|
| LUNG | 100% | +1.75% | ||
| BDX - LUNG | 35% Loosely correlated | +2.22% | ||
| CERS - LUNG | 32% Poorly correlated | -4.64% | ||
| UTMD - LUNG | 31% Poorly correlated | +0.59% | ||
| KIDS - LUNG | 30% Poorly correlated | +1.44% | ||
| SNN - LUNG | 29% Poorly correlated | +0.40% | ||
More | ||||
XVIPF and
Correlation & Price change
A.I.dvisor tells us that XVIPF and INMD have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and INMD's prices will move in lockstep.
| Ticker / NAME | Correlation To XVIPF | 1D Price Change % | ||
|---|---|---|---|---|
| XVIPF | 100% | N/A | ||
| INMD - XVIPF | 20% Poorly correlated | +0.81% | ||
| LUNG - XVIPF | 8% Poorly correlated | +1.75% | ||
| VPTDF - XVIPF | 7% Poorly correlated | -4.16% | ||
| OM - XVIPF | 6% Poorly correlated | -1.29% | ||
| USAQ - XVIPF | 4% Poorly correlated | +22.22% | ||
More | ||||